Hospitals & Health Systems

A key deal locking in generic drug prices is extended, promising billions in savings for healthcare and providing crucial stability for a fragile industry.

Nancy Torres analyzes Héma-Québec's summer tour, revealing a sophisticated strategy to combat supply chain risks, secure plasma independence, and diversify its donor base.

The 529 Network's rebrand reflects a major shift in education, as savings plans now cover apprenticeships, K-12, and even student loan repayment.

A landmark agreement gives Premier's 4,350-hospital network streamlined access to Bluesight’s AI-powered suite for drug diversion and supply chain management.

As college grads face underemployment, a new nonprofit is giving high schoolers paid entry into healthcare and maritime, redefining the path to success.

Federal cuts are pushing 450,000 New Yorkers off the Essential Plan. Here’s what you need to know to avoid a coverage gap and find a new plan now.

With its pivotal Phase 3 trial complete, Rafael Holdings is on a path to redefine treatment for NPC and transform itself into a commercial-stage biotech.

A new 225-residence community breaks ground in Issaquah, aiming to address the Eastside's senior housing shortage with an integrated healthcare model.

Sanofi's promising nerve disease drug fails in late-stage trials, leaving vulnerable patients in limbo and highlighting the brutal realities of medical innovation.

How a Swedish city's new aquatic center, powered by unique CO₂ technology, reveals a future where public infrastructure can be both sustainable and strategic.

Facing burnout and fearing for patient safety, 250 clinicians at Seattle's top cancer centers are unionizing, challenging the very structure of modern healthcare.

A novel TYK2 inhibitor that can enter the central nervous system has begun human trials, signaling a new frontier for treating diseases like MS and lupus.

Asante and WesternU launch a strategic partnership to embed medical students in the Rogue Valley, tackling physician shortages with a 'grow your own' model.

Facing a complex and costly senior care market, two disabled veterans launch Trua of Greater Boston, a free service aimed at providing compassionate guidance.

New long-term data for masitinib shows a near doubling of 5-year survival for ALS patients, with many maintaining quality of life. Is this the turning point?

A strategic leadership shift at BoldAge PACE signals a major push to expand its home-based senior care model, aiming to transform how America ages.

Nearly half of all car seats are used incorrectly, a fatal mistake for thousands. A Chicago partnership shows how corporate capital can deliver life-saving results.

Dana-Farber's historic $50M Yawkey grant funds more than a building; it fuels a new era of integrated research and patient-centric cancer treatment.

A $20M round for CELYSTRA Pharma isn't just a launch; it's a strategic maneuver to solve Canada's rare disease gap and redefine Québec's role in the market.

New data reveals a grim reality: Texas rural roads are nearly three times deadlier than city streets, exposing a deep infrastructure and safety crisis.